ArticleEuropean journal of histochemistry : EJH2025
Transient receptor potential canonical 3/5 attenuate endothelial damage-induced neointima formation without affecting endothelial cell proliferation.
Article in European journal of histochemistry : EJH, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Store-operated calcium channels (SOCCs) are involved in the process of cell proliferation; however, their expression levels differ among cell types and information on their effects in different cells is lacking. This study aimed to compare the differing effects of SOCCs on the proliferation of vascular smooth muscle cells (VSMCs) and vascular endothelial cells (VECs), and the repair ability of SOCC after vascular endothelial injury. Rat primary coronary VSMCs and VECs were cultured in vitro and expression levels of SOCC molecules were detected by western blotting and quantitative polymerase chain reaction. Various molecules were selected and transfected into VSMCs and VECs using an adenovirus vector, and cell proliferation, the cell cycle, and intracellular Ca2+ were then detected. We also established a rat carotid artery endothelial injury model to verify the results of the in vitro experiments. Expression levels of transient receptor potential canonical (TRPC) 3 and TRPC5 were higher in VSMCs than in VECs. Silencing TRPC3/5 significantly inhibited cell proliferation and Ca2+ influx in VSMCs, but not in VECs. Silencing TRPC3/5 after rat carotid artery endothelial injury inhibited neointima formation, with a better reparative effect on the endothelial cell layer than rapamycin. TRPC3/5 participates in the proliferation of VSMCs via SOCCs, and silencing its expression inhibits the formation of neointima after endothelial injury. However, this effect was not significant in VECs, suggesting that other compensatory pathways may have emerged.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.